Track topics on Twitter Track topics that are important to you
Merck & Co., Samsung Bioepis terminate deal to develop Lantus biosimilar https://www.firstwordpharma.com/node/1597145?tsid=28®ion_id=6 …NEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...